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The neurological dysfunction in amyotrophic lateral sclerosis (ALS)/motor neurone
disease (MND) is associated with defective nerve-muscle contacts early in the disease
suggesting that perturbations of cell adhesion molecules (CAMs) linking the pre- and
post-synaptic components of the neuromuscular junction (NMJ) are involved. To search
for candidate proteins implicated in this degenerative process, researchers have studied
the Drosophila larval NMJ and find that the cytoskeleton-associated protein, adducin,
is ideally placed to regulate synaptic contacts. By controlling the levels of synaptic
proteins, adducin can de-stabilize synaptic contacts. Interestingly, elevated levels of
phosphorylated adducin have been reported in ALS patients and in a mouse model
of the disease. Adducin is regulated by phosphorylation through protein kinase C
(PKC), some isoforms of which exhibit Ca2+-dependence, raising the possibility that
changes in intracellular Ca2+ might alter PKC activation and secondarily influence
adducin phosphorylation. Furthermore, adducin has interactions with the alpha subunit
of the Na+/K+-ATPase. Thus, the phosphorylation of adducin may secondarily influence
synaptic stability at the NMJ and so influence pre- and post-synaptic integrity at the NMJ
in ALS.
Keywords: amyotrophic lateral sclerosis, neuromuscular junction, adducin, Hu-li tai shao, Discs large, neural cell
adhesion molecule
THE NEURODEGENERATIVE DISEASE AMYOTROPHIC LATERAL
SCLEROSIS
The neurodegenerative disorder amyotrophic lateral sclerosis (ALS), also known as motor
neurone disease (MND), is a motor system disease that causes progressive motoneuron loss
in the spinal cord and brainstem leading to weakness and loss of muscle innervation (i.e.,
denervation), as well as the degeneration of descending motor tracts from the brain and
subcortical structures resulting in spasticity (Eisen and Krieger, 2006; Su et al., 2014). Death
typically occurs within 2–5 years of diagnosis, usually resulting from respiratory failure due
to respiratory muscle weakness. At post-mortem, ALS patients have lost large numbers of
spinal motoneurons, interneurons and other neuronal populations, but with considerable
side-to-side asymmetry and variability at spinal and brain stem levels (Tsukagoshi et al., 1979;
Swash et al., 1986). These findings are, by their very nature, end-stage effects and do not
reflect the early stages of the disease. The large majority of ALS cases appear sporadically in
the general population without evidence for an inherited gene mutation (‘‘sporadic ALS’’).
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However, genes associated with ALS susceptibility are being
defined (Keller et al., 2014) and mutations in various genes are
sometimes found in patients with sporadic ALS. In 5–10% of
ALS patients, the disease has an autosomal dominant or, in rare
cases, autosomal recessive inheritance, and is termed familial
ALS (FALS; Andersen and Al-Chalabi, 2011). Gene mutations
associated with FALS have been under intense scrutiny, and
such mutations are currently identified in approximately 50%
of FALS patients. Observed in the highest percentage of
FALS patients are mutations in Cu/Zn superoxide dismutase 1
(SOD1) and chromosome 9 open reading frame 72 (C9ORF72;
Vucic et al., 2014). However, mutations in TAR DNA-binding
protein 43 (TDP-43, TARDBP), fused in sarcoma/translocated in
liposarcoma (FUS/TLS), vesicle-associated membrane protein-
associated protein B (VAPB) and other genes have been reported
(Andersen and Al-Chalabi, 2011). The functional diversity of
the proteins associated with these gene mutations (e.g., SOD1,
a cytosolic anti-oxidant; VAPB, a synaptic membrane-associated
protein; and others) makes it unlikely that a single disease-
initiating event will be present, but rather that a number of
unique triggering events will result in a common pathogenic
process leading to muscle denervation. Mutations in genes for
isoforms of the cytoskeletal protein adducin have not been
reported in FALS patients nor have mutations been found in
genes for proteins which interact with adducin. Rarely, missense
mutations are found in genes for synaptic proteins such as
VAPB, both in FALS and in sporadic ALS (Millecamps et al.,
2010). Although the expression of mutant VAPB in Drosophila
melanogaster is associated with neuromuscular junction (NMJ)
defects such as increased numbers of synaptic boutons at the
NMJ and decreased bouton size, as well as locomotor defects,
VAPB has numerous effects in neurons and it is not possible to
conclude that VAPB mutations produce a phenotype that results
exclusively from synaptic dysfunction (Sanhueza et al., 2014).
There are some differences in the clinical features of FALS due
to distinct mutations in comparison to sporadic ALS (Stewart
et al., 2012). However, in the absence of a family history,
it is virtually impossible to distinguish FALS patients from
those with sporadic ALS, suggesting that sporadic and FALS
are mechanistically similar and that insights into FALS will be
relevant for an understanding of sporadic ALS. Although it is
clear that specific gene mutations result in ALS, it is not clear
how thesemutations result in disease. In this review, we will focus
on the evidence that ALS results from synaptic dysfunction at
the NMJ as well as at other synapses. We recognize that there
is also evidence for other explanations as causative for ALS. We
will also highlight the importance of cytoskeletal proteins such
as adducin as being a modulator for the synaptic dysfunction
in ALS.
SELECTIVE VULNERABILITY OF
MOTONEURONS IN ALS
It is likely that ALS develops as a consequence of the selective
vulnerability of motoneurons or the axonal pathways from
the brain and brainstem that descend to motoneurons to
undergo dysfunction and cell death. The descending motor
tracts that innervate motoneurons include the corticospinal
tract and other descending motor tracts from the brain and
brainstem. The vulnerability of motoneurons is produced by
the large size of these cells, their large caliber and long
axons, the abundant dendritic projections, and the high
metabolic cost of action potential generation in motoneurons
(Le Masson et al., 2014). Additionally, there is possibly a
toxic environment surrounding motoneurons, including the
presence of microglia and astrocytes that might be responsible
for non-cell autonomous toxicity (Julien, 2007; Ikiz et al., 2015).
Furthermore, motoneurons exhibit an abundance of excitatory
amino acid (EAA) receptors including N-methyl-D-aspartate
(NMDA) receptors, and some of these receptor channels
have calcium permeability. Stimulation of EAA and/or NMDA
receptors can lead to excitotoxicity which is likely accompanied
by raised intracellular Ca2+ concentrations ([Ca2+]i) in the cell
body, but alternatively could occur in the post-synaptic region
or pre-synaptic terminal. Motoneurons have lower levels of
calcium buffering proteins, such as calbindin, than do other
neuronal types, thus possibly enhancing the toxicity of elevated
[Ca2+]i. Because of the vulnerability of the motoneuron to
injury, previous hypotheses of neuronal dysfunction in ALS
have focused on excitotoxicity, axonal dysfunction, or aberrant
RNA processing in motoneurons. Elevations of [Ca2+]i are
capable of activating Ca2+-dependent protein kinases such as
some isoforms of protein kinase C (PKC). One consequence of
PKC activation is the increased phosphorylation of cytoskeletal
proteins such as adducin (Krieger et al., 2003). As described
below, adducin is present at the synapse both presynaptically
and postsynaptically and exists in phosphorylated and non-
phosphorylated forms. Non-phosphorylated adducin links actin
and spectrin filaments and provides stability to the NMJ. When
adducin is phosphorylated by PKC or other protein kinase
adducin will translocate from the membrane, where it likely
stabilizes the synapse, to the cytosol. This will result in a
de-stabilization of the synapse which can be important for
synaptic plasticity such as in learning but may reduce the ability
of the NMJ to form strong connections between pre-synaptic
and post-synaptic contacts. Thus indirectly, the elevations of
[Ca2+]i lead to destabilization of the synapse, especially at the
NMJ, mediated in part through adducin. We recognize that
this view is simplistic, as adducin effects are likely different
at pre- and post-synaptic regions (Pielage et al., 2011; Wang
et al., 2011, 2014) and that elevations in [Ca2+]i will have
many effects. Nonetheless, it is the purpose of this review to
highlight the potential role played by cytoskeletal proteins in
general and adducin in particular as mediators for some of
the reactions of motoneurons to cell stress including impaired
synaptic connectivity.
Also important is that the motoneuron is surrounded by
non-neuronal cells such as astrocytes, microglia and terminal
Schwann cells which when activated could result in motoneuron
damage (Julien, 2007). Evidence for non-cell autonomous
damage to motoneurons in the pathogenesis of ALS is
strong given studies in transgenic mice that neuron-specific
expression of mutant proteins generally does not result in
muchmotoneuron loss whereas ubiquitous expression of mutant
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proteins will produce profound motoneuron dysfunction (Ilieva
et al., 2009; Ikiz et al., 2015). Although not well studied, it is likely
that the effects of adducin phosphorylation in non-neuronal cells
will be different from the effects of phosphorylated adducin at
the NMJ.
ALS INITIALLY AFFECTS THE DISTAL
MOTONEURON AXON AND
NEUROMUSCULAR SYNAPSE
Attempts to delineate early changes in ALS, as opposed to those
at end-stages, have focused on biopsy material from ALS patients
and controls, as well as studies in widely used animal models of
ALS such as transgenic rodents over-expressing human mutant
SOD (mSOD), which manifest motoneuron degeneration similar
to that seen in ALS patients (Turner and Talbot, 2008). Studies
involving mSOD mice have shown that motoneuron loss is
prominent but not complete such that approximately 50% of
motoneurons are still evident even in animals in the terminal
stages of disease (Parkhouse et al., 2008; Turner and Talbot,
2008). These observations demonstrate that motoneurons and
their proximal axons are still present in the late stages of
the disease, but that many of the axons are incapable of
forming functional NMJs with skeletal muscle (i.e., denervation)
leading to muscle weakness. Furthermore, these axons are
often unable to re-establish stable contacts with muscle once
denervation has occurred (i.e., impaired re-innervation). This
view is supported by evidence that motoneurons in mSOD mice
with advanced disease can still be identified using morphological
or immunohistochemical techniques, yet, they will not manifest
labeling with retrograde markers such as FluoroGold delivered to
themuscle, which would normally be taken up by the presynaptic
terminals and transported in the retrograde direction to the
cell bodies (Parkhouse et al., 2008). This is presumably due
to loss of axon integrity at either the proximal or distal axon
(Kennel et al., 1996). The capacity for compensatory axonal
sprouting is strikingly reduced in ALS, even when compared to
anothermotor neuron disease such as poliomyelitis. Interestingly
in patients who develop poliomyelitis and have considerable
motoneuron loss, the few surviving motoneurons are able
to re-innervate muscle and compensate for the reduction in
motoneuron number even when the motoneuron losses are as
extensive as in some patients with ALS (Trojan and Cashman,
2005). Several studies that examined biopsies obtained from
patients with ALS early in the disease have confirmed that
muscle denervation is extensive, and develops prior to significant
motoneuron loss (Fischer et al., 2004). The impairment in the
ability of motoneurons to re-innervate muscle may also be the
case in normal aging, but to a much lesser extent (Valdez et al.,
2012). The degenerative process of ALS may initially lead to
impaired function of the distal axon (so called ‘‘axonopathy’’),
with relative preservation of the cell body and proximal axon,
thus offering hope that if axonal function can be stabilized, then
the axonal loss can be halted or even reversed and the disease
progression can be attenuated. The role of axonal transport in
neurodegenerative disease has been reviewed previously (De Vos
et al., 2008).
The predominant features of ALS at the motoneuron,
as distinct from axonal loss in the central nervous system
(CNS), are weakness and fasciculations. Fasciculations are brief,
spontaneous contractions of a limited number of muscle fibres
which may arise from the spontaneous firing of motoneurons or
their axons. Motor weakness is not exclusively found in ALS and
can be present inmany conditions due to impaired functioning of
different regions of the motoneuron. For instance, some forms of
neuropathy target the axon of the motoneuron (‘‘axonopathy’’).
Some types of axonopathy have been referred to as a ‘‘dying
back’’ process, where the longest and largest motor axons are
targeted first, and the initial impairment affects the most distal
portions of the axon (also called ‘‘distal axonopathy’’), such
as at the pre-synaptic terminal. Subsequently, more proximal
portions of the axon become affected in the disorder. This
view is based on neuropathological evaluation of some types of
toxin-induced peripheral nerve damage (peripheral neuropathy)
such as that following extensive alcohol consumption, where
the fine intramuscular nerve branches of motoneurons may
be affected initially while more proximal axons are spared.
Presumably, the most distal aspects of the nerve are more
susceptible to some toxins or to axonal ‘‘undernourishment’’, or
impaired axon transport associated with the actions of a toxin
(Cavanagh, 1979). An additional clinical condition resulting
in weakness that is likely due to impaired distal axon and
NMJ function are some forms of critical illness polyneuropathy
(Hermans and Van den Berghe, 2015). This evidence collectively
supports the view that a loss of nerve-muscle contacts occurs
early in the disease, which might represent the inability of
presynaptic motoneuron terminals to re-innervate muscle at the
NMJ (Moloney et al., 2014). However, it also should be kept
in mind that transgenic mice with neuron-specific expression
of mSOD do not develop disease with the same characteristics
as with ubiquitous expression of mSOD, raising the likelihood
that ALS is a disease not only of neurons, but also neurons
and their non-neuronal neighbors (Julien, 2007; Ilieva et al.,
2009; Meyer et al., 2014). These types of studies have not
suggested that muscle cells were a cell type that is responsible
for development of murine or human ALS (Miller et al.,
2006).
Numerous factors are responsible for nerve-muscle
interactions, both during development and at the mature
synapse. The integrity of cell adhesion molecules (CAMs)
that link the pre- and post-synaptic regions is undoubtedly
relevant for the functionality of neuromuscular control.
However, the link between structure and function at the
NMJ is complex with numerous interactions between NMJ
components and considerable functional redundancy for
proteins at the NMJ (Koper et al., 2012). There are many
evolutionarily conserved synaptic CAMs such as cadherins,
integrins, neurexins and others. Physiological activation of the
NMJ also has profound effects where pre- or post-synaptic
cholinergic antagonism with botulinum toxin, or bungarotoxin,
have similar effects to surgical denervation (Avila et al., 1989).
It is also clear that perisynaptic Schwann cells (also called
‘‘terminal Schwann cells’’) exert important roles in synapse
re-organization at the NMJ in ALS (Arbour et al., 2015).
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 January 2016 | Volume 10 | Article 11
Krieger et al. Adducin at the NMJ in ALS
As will be discussed below there is evidence that one of
these CAMs such as a Drosophila orthologue of neural cell
adhesion molecule (N-CAM) interact indirectly with synaptic
adducin.
Mammalian motoneurons have different physical and firing
characteristics that can be roughly grouped into distinct classes,
such as fast-fatigable (FF) and slow (S; Burke, 1967; Heckman
and Enoka, 2012). Interestingly, there are differences in the
susceptibility of various synaptic subtypes to degeneration in
ALS, with synapses of FF motoneurons being vulnerable to
synaptic loss and synapses of slow motoneurons being relatively
resistant (Frey et al., 2000; Pun et al., 2006; Hegedus et al., 2008).
In addition, with disease there may be an activity-dependent
conversion of motoneuron types towards a slow phenotype (Frey
et al., 2000). The progressive weakening of specific synapses
with disease suggests synapse-specific mechanisms as being at
least partially responsible for selective synaptic loss. This view
is supported to some degree by the observation that the WldS
gene, which protects against axonal injury, modestly prolongs
survival in the mSOD mouse and other murine models of ALS
(Ferri et al., 2003; Fischer et al., 2005). Synaptic terminals that are
less susceptible to denervation also demonstrate more ability to
generate stimulus-induced synaptic sprouting, which could arise
from differences in the regulation of the actin cytoskeleton of the
different synaptic types (Laux et al., 2000).
One additional piece of circumstantial evidence for the
presence of distal axon or synaptic terminal dysfunction in ALS
is the finding of decremental responses in muscle to repetitive
nerve stimulation both clinically in ALS patients and in models
of ALS (Kennel et al., 1996; Iwanami et al., 2011; Piotrkiewicz and
Hausmanowa-Petrusewicz, 2013). That is, when motoneuron
axons are stimulated repetitively, there is a reduction in the
amplitude of the evoked response in muscle suggesting an
impairment of neuromuscular transmission at the NMJ. ALS also
includes involvement of CNS structures and it has not yet been
determined whether involvement of the motoneuron precedes
dysfunction in descending axons, or if the two processes occur
concurrently, or in the reverse order (Dengler, 2011).
MITOCHONDRIAL DYSFUNCTION IN ALS
Mitochondrial dysfunction has been linked with many
neurodegenerative conditions, including ALS (Schon and
Przedborski, 2011; Cozzolino et al., 2015). However, it is not
clear how mitochondrial dysfunction arises in ALS and whether
the impairment is an initiating feature of the disease, or a
consequence of the motoneuron dysregulation that arises from
other causes. Impaired mitochondrial function likely leads
to defective bioenergetics, but could also produce defective
mitochondrial trafficking, impaired mitochondrial fusion and
fission, as well as altered mitochondrial quality control (Schon
and Przedborski, 2011). For instance, mitochondrial disruption
has been reported to contribute to SOD1-mediated motoneuron
degeneration (Jaiswal and Keller, 2009). Motoneurons are large,
actively firing cells having very demanding ATP-dependence
to maintain the resting membrane potential, neurotransmitter
release and other functions. Of relevance to this review are
observations that the cytoskeletal protein adducin is associated
with and directly interacts with the α-subunit of the Na+/K+-
ATPase (Ferrandi et al., 1999; Torielli et al., 2008). Mutations in
α-adducin are associated with hypertension in rats and humans
which is presumably based on aberrant interactions between
the mutant α-adducin and Na+/K+-ATPase (Torielli et al.,
2008). Although it is beyond the scope of this review to discuss
mitochondrial function in ALS, it is relevant that a major energy
consumer in the neuron is the Na+/K+-ATPase which is essential
for providing energy for neuronal repolarization following an
action potential. Recent modelling studies of ATP utilization in
model neurons have suggested that the amount of ATP required
for ion homeostasis is closely matched by energy production
(Le Masson et al., 2014). Under conditions where motoneurons
produce high frequency action potential firing, especially in
fast fatiguable motoneurons, reductions in steady state ATP
levels can occur. Modelling studies of action potential firing
in excess of 20 Hz suggest that motoneurons cannot support
continued Na+/K+-ATPase activity and neurons will depolarize
(Le Masson et al., 2014). This also might lead to aberrant action
potential firing, such as is seen clinically in the appearance of
‘‘fasciculations’’, the spontaneous discharges of motor units
that may be related to abnormal motoneuron discharge (de
Carvalho et al., 2014). Furthermore, modelling studies also
suggest that the energetic cost to support the vulnerable, ‘‘FF’’
motoneurons is higher than for the ‘‘S’’ motoneurons providing
a possible explanation for the differential vulnerability of the
two motoneuron subpopulations as is seen in ALS (Le Masson
et al., 2014). Fasciculations arise from spontaneous motoneuron
firing at the cell body, axon or other sites (de Carvalho et al.,
2014).
COULD MOLECULES MEDIATING CELL
ADHESION BE RELEVANT FOR THE
PATHOGENESIS OF ALS?
One approach to determine which molecules could be relevant
for the pathogenesis of ALS would be to compare the biochemical
profiles of synapses that are retained in ALS with those that
are lost. This can be attempted by comparing NMJs from
biopsy material from the limb muscles that are typically
involved in ALS, with NMJs in extraocular muscles, which
usually are not involved in ALS. One such study has claimed
that significant reductions in the immunoreactivity of the
extracellular matrix protein, α4 laminin, are seen in the NMJs
of limb muscles in ALS patients, but are not as affected in the
NMJs of extraocular muscles (Liu et al., 2011). It is possible
that these immunohistochemical findings are related to the
disruption of the NMJ, rather than being causative, but the
results suggest that the integrity of the basement membrane
surrounding the muscle fibre may be important for synapse
stability. Interestingly, removal of Laminin A in Drosophila
embryos causes a reduction in NMJ adhesion, and it has
been proposed that the basement membrane contributes to
adhesion of the motoneuron terminal to the muscle (Koper et al.,
2012).
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A potentially relevant CAM for ALS is the N-CAM and its
homologue in the fly, Fasciclin 2 (Fas2). Mice lacking N-CAM
in presynaptic terminals have impaired muscle re-innervation
following denervation, emphasizing the important role played
by N-CAM for re-innervation (Chipman et al., 2014a). It is also
well established that at the simpler Drosophila NMJ, Fas2 is
necessary for synaptic stabilization and plasticity (Schuster et al.,
1996a,b). Furthermore, the proportion of denervated muscle
fibres in transgenic mice overexpressing mSOD as identified
using N-CAM immunoreactivity correlates well with the rate
of decline of muscle contractile force in these mice (Gordon
et al., 2009). When pluripotent stem cells are directed to
differentiate into motoneurons, motoneuron stem cells lacking
N-CAM have well defined structural and functional deficits
at the NMJ (Chipman et al., 2014b). These deficits may
be less pronounced than when N-CAM is lost from both
pre- and post-synaptic sites. The mechanisms underlying the
actions of N-CAM and Fas2 in modulating re-innervation at
the NMJ are under investigation. However, it would seem
important to study proteins that could have an impact on
these CAMs and that these molecules deserve further scrutiny
in ALS. In the following section we focus on a cytoskeletal
protein that interacts with many other proteins at the NMJ
and is likely relevant for understanding the pathophysiology
of ALS.
ADDUCIN AT THE NMJ
The Distal Axon and Synapse are
Regulated by the Actin Cytoskeleton
Actin and spectrin are cytoskeletal proteins whose interactions
are critical for the morphology of the presynaptic terminal
and the post-synaptic region. The association of these proteins
is relatively weak, and spectrin requires accessory proteins
to assemble and stabilize spectrin-actin interactions, which
include the cytoskeletal accessory proteins adducin and protein
4.1 (Bennett and Baines, 2001). These interactions permit
the cytoskeleton to provide several functions that have been
clarified through study of the erythrocyte membrane: they
allow structural support through the lattice-like arrangement
of the fibrils of filamentous actin and spectrin; they provide
a platform on which many accessory proteins can bind;
and through the variation in the lattice sizes of actin and
spectrin, they can likely modulate the structural strength
of local regions of the membrane. Adducin is a tetramer
composed of α, β and γ subunits, where interactions with
actin and spectrin are mediated by the carboxy-terminal region
of adducin that has homology to a myristoylated alanine-
rich C-kinase substrate (MARCKS)-related domain (Matsuoka
et al., 2000). This highly basic, charged MARCKS domain
likely permits adducin to associate (i.e., ‘‘hang on’’) to the
cell membrane, and sequester highly charged phosphoinositides
(PIs) such as PI(4,5)P2 (Denisov et al., 1998; Figure 1). Adducin
also associates with the sides and fast-growing ends of actin
filaments, and exhibits high affinity for actin-spectrin complexes
(Matsuoka et al., 2000; Figure 2). In this sense, adducin
‘‘hangs on’’ to the cytoskeleton and thus serves as a linker
between the cell membrane and the cytoskeleton. The MARCKS
region contains a phosphorylation site that is modulated by
Ca2+/calmodulin and PKC, where the phosphorylation of
adducin inhibits the stabilization of actin-spectrin complexes
(Matsuoka et al., 2000; Figure 2). Interestingly, mammalian
adducin and its invertebrate homologues have a number
of defined synaptic protein-protein interactions including
Na+/K+-ATPase, Discs large (Dlg) and Golden Goal (Gogo;
Ohler et al., 2011; Wang et al., 2011, 2014; Gallardo et al., 2014;
Figure 2).
A Role for Adducin and Phosphorylated
Adducin in ALS
Adducin is of interest in ALS as there are high levels of
phosphorylated adducin (phospho-adducin) protein in spinal
cord tissue from patients who died with ALS compared
to individuals who died without neurological disease (Hu
et al., 2003). Furthermore, immunocytochemistry of murine
spinal cord tissue demonstrated that phospho-adducin
immunoreactivity was significantly higher in mSOD spinal
cord tissue compared to control tissue (Shan et al., 2005).
Recently, both of these observations have been confirmed and
the association between adducin and ALS extended (Gallardo
et al., 2014). It is possible that excessive levels of phosphorylated
adducin would create instability at the NMJ and knockdown
of α-adducin by RNA interference (RNAi) in mSOD over-
expressing mice results in greater motoneuron survival than in
the absence of RNAi. The effects of elevations in phosphorylated
adducin are likely not restricted to motoneurons as knockdown
of α-adducin in the astrocyte population of co-cultured wild-type
motoneurons with astrocytes over-expressing mSOD resulted
in less motoneuron death. Gallardo et al. (2014) suggest that
α-adducin mediates motoneuron degeneration in mSOD mice
and potentially in human ALS as well. Evidence supporting
involvement of adducin in ALS is shown in Table 1. Both
we and Gallardo et al. (2014) have expressed the view that
the effects of adducin in ALS are not mediated entirely by
adducin, but are likely dependent on interactions between
adducin and other proteins. Gallardo et al. (2014) have focused
on interactions between α-adducin and the Na+/K+-ATPase,
a protein that has been well-established to associate with
adducin where this interaction has been of considerable
interest with regard to the role of adducin polymorphisms
in essential hypertension (i.e., high blood pressure). To
our knowledge, the possible relevance of polymorphisms in
α-adducin genes for the development of ALS has not been
evaluated.
The work of Gallardo et al. (2014) indicates that a gain of
adducin function may have a causative role in ALS, especially
in astrocytes, whereas a recent study from Costessi et al.
(2014) proposes that a loss of adducin function may be
involved. TDP-43 is an RNA-binding protein found to be a
major component of pathological cytoplasmic inclusions in
ALS and as such, perturbed TDP-43 function may be linked
to neurodegeneration. Costessi et al. (2014) demonstrated that
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FIGURE 1 | Adducin hangs on to the membrane. Schematic diagram showing the MARCKS domain of Adducin/Hts (amino acid sequence shown) acting to
sequester PIP2 (shown as yellow lipids) in the plasma membrane. Protein kinase C (PKC) phosphorylation of the serine (underlined) in the basic effector domain of
MARCKS reduces the electrostatic interaction with the membrane and causes translocation of adducin/Hts from the plasma membrane to the cytoplasm (see
Figure 2).
TDP-43 regulates adducin 2 gene expression by promoting
adducin 2 mRNA stability, and suggest that loss of adducin
function through disruption of TDP-43 activity may contribute
to ALS.
These various studies indicate that misregulation of adducin
activity through hyper-phosphorylation or changes in gene
expression may be a contributing factor in the etiology of
ALS. An alternative view could be that as many proteins are
hyper-phosphorylated in ALS, adducin phosphorylation may be
just one of many hyper-phosphorylated proteins in the disease
(Krieger et al., 2003), and of little direct relevance. However,
although not a ‘‘primary cause’’ for ALS, it is also possible that
the hyper-phosphorylation or other misregulation of adducin
is responsible for some of the particularly malicious aspects of
ALS, namely the inability of denervated presynaptic terminals to
re-innervate muscle and sustain life.
Two Functions of Adducin at the
Drosophila NMJ: Stabilizing the
Presynaptic Terminal and Regulating
Adhesion in the Post-Synaptic Region
Because of the strengths of Drosophila genetics, researchers
have turned to the Drosophila larval NMJ for evaluation of
adducin/Hts function in the nervous system. Presynaptically,
spectrin-actin lattices are important for establishing a platform
for regulating neurotransmitter release. Postsynaptically, these
lattices are also present where they are responsible for the spacing
and efficacy of the NMJ (Pielage et al., 2006). Two groups have
shown that adducin/Hts is present in both the pre- and post-
synaptic regions and that perturbations of adducin/Hts levels can
influence the extent of synaptic branching of the NMJ (Pielage
et al., 2011; Wang et al., 2011; Figure 3).
Adducin/Hts acts to maintain the presynaptic cytoskeletal
organization, as well as to preserve contacts between the
presynaptic terminal and muscle, as shown diagrammatically
in Figure 3. Pielage et al. (2011) focused on the role of
pre-synaptic adducin/Hts, where they provide evidence that
it regulates synaptic structure through its role as an actin-
capping protein (Figures 3A,B). Of particular interest is
their finding that loss of pre-synaptic adducin/Hts causes
both overgrowth of the synaptic arbor and its retraction
from the muscle, a phenotype particularly relevant to ALS
(Figures 3C,D). By contrast, post-synaptic adducin/Hts has a
distinct role from pre-synaptic adducin/Hts, which acts as an
inhibitor of adhesion between nerve and muscle. The ability
to break adhesion and then re-form contacts between nerve
and muscle is important for growth of the synapse during
development (Schuster et al., 1996a), and the loss of post-
synaptic Hts prevents synaptic growth, possibly due to increased
adhesion between nerve and muscle (Figure 3E). Conversely,
post-synaptic overexpression of Hts may promote synaptic
overgrowth by reducing adhesion between nerve and muscle
(Figure 3D).
Over-expression of adducin/Hts in the muscle results
in delocalization of the key postsynaptic protein, Dlg.
Co-immunoprecipitation and proximity ligation assay
experiments demonstrate that adducin/Hts is present in a
complex with Dlg at the NMJ (Wang et al., 2011, 2014, 2015).
These results suggest that the synaptic function of adducin/Hts
may be mediated, at least in part, through interactions with
Dlg. But how does Hts regulate Dlg postsynaptic targeting?
A relevant finding is that adducin/Hts over-expression leads
to increases in muscle immunoreactivity against PAR-1 and
CaMKII, two protein kinases known to phosphorylate Dlg
and disrupt its localization at the post-synaptic membrane
(Koh et al., 1999; Zhang et al., 2007; Wang et al., 2011).
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FIGURE 2 | Adducin hangs on to the cytoskeleton where it modulates synaptic structure. Model of Adducin/Hts and interacting proteins at the
neuromuscular junction (NMJ). Model shows a lateral view of an NMJ with presynaptic membrane shown above. Post-synaptically, Adducin/Hts (“Hts/Add”) is
localized to actin-spectrin junctions and is found associated with Dlg, possibly through binding to Coracle (Cora). Homophilic adhesion between Fas2 molecules links
the pre- and post-synaptic membranes, with the intracellular domain of Fas2 anchored to Dlg. Also associated with Hts is the α-subunit of the Na+/K+-ATPase.
(Continued)
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FIGURE 2 | Continued
Based on studies of mammalian adducin, we speculate that when
phosphorylated, Hts translocates from the membrane and its subsequent
dephosphorylation may enable Hts access to the nucleus. In the nucleus, Hts
is involved in export of transcripts for the kinases PAR-1 and CaMKII. PAR-1
and CaMKII subsequently phosphorylate the scaffolding molecule Dlg, which
delocalizes from the NMJ, leading to reduced adhesion between nerve and
muscle. In this model Hts monitors the status of the NMJ and can promote
synaptic plasticity by shuttling to the nucleus.
Thus, it appears that adducin/Hts regulates synaptic size by
controlling Dlg localization at the postsynaptic membrane
via PAR-1 and CaMKII-mediated phosphorylation. Dlg
interacts with Fas2, which, as mentioned above, is the
homolog of mammalian N-CAM (Thomas et al., 1997).
Previous studies indicate that Dlg and Fas2 regulate synaptic
plasticity and stabilization, and the Drosophila NMJ may
prove ideal in addressing regulation of synaptic adhesion by
adducin/Hts.
Adducin is Present in Synapses of the
Mammalian CNS
This review has focused on the action of adducin in relation
to ALS through its action at the motoneuron and NMJ.
However, ALS also affects the CNS, and adducin and phospho-
adducin are widely distributed throughout the mammalian
nervous system, especially in axons and presynaptic nerve
terminals, regions that are likely relevant for the initiation
of neurodegeneration in ALS (Seidel et al., 1995; Xu et al.,
2013). Of interest is the observation that β-adducin knock-out
mice have defects in learning, as well as long-term potentiation
and long-term depression (Porro et al., 2010). β-adducin may
be required specifically for the establishment of synapses in
the CNS under conditions of an ‘‘enriched environment’’, an
environment where animals are exposed to more sensory stimuli
than normal which results in augmented synaptogenesis and
improved learning ability (Bednarek and Caroni, 2011). These
effects of β-adducin in learning are thought to be due to
adducin augmenting the outgrowth of one type of synaptic
input to inhibitory interneurons in the hippocampus (Ruediger
et al., 2011). It is tantalizing to speculate that the specific
effect of adducin in synaptic circuitry might occur through
an interaction with Dlg. A mammalian homologue of Dlg
is PSD-95, a post-synaptic protein found in excitatory, but
not at inhibitory synapses. Thus, modulation of adducin at
excitatory and inhibitory synapses would occur differently, as
it is likely that adducin would also be found at inhibitory
synapses. Adducin is also found in cerebellar Purkinje cells
where it associates with an enzyme that generates inositol
pyrophosphates (inositol hexakisphosphate kinase-3; IP6K3)
and IP6K3 knockout mice have impaired motor learning and
coordination, possibly related to impaired disposition of adducin
(Fu et al., 2015).
Interestingly, the nematode homologue of adducin, Add-1,
has also been drawn into the debate about whether the act
of forgetting memories is an active or passive process. Studies
in C. elegans have suggested that the long term retention of
learned material in this animal is facilitated by Add-1 and
inhibited by single stranded RNAs of the mushashi (msi-1)
family (Hadziselimovic et al., 2014). These data underscore that
adducin has been involved in synaptic architecture for a long
time from an evolutionary point of view and is central to synaptic
function even in simple organisms.
Circumstantial evidence for the importance of adducin/Hts
in CNS function is also provided by recent studies showing that
mutations in γ-adducin are associated with familial cerebral palsy
(Kruer et al., 2013). Additionally, adducin has been reported
to be a binding partner for chorein, a protein believed critical
for development of the movement disorder chorea-acanthosis
(Shiokawa et al., 2013).
Adducin: A Reporter of Synaptic Activity at
the Nucleus and a Regulator of
Transcription at the Synapse?
Although this review has focused on the role of adducin/Hts
at the NMJ, there are studies that indicate nuclear functions
for adducin that might be relevant to its roles at the synapse.
α-adducin contains nuclear localization and export signals, and
has been shown to translocate to the nucleus in cultured epithelial
TABLE 1 | Adducin in nervous system function and dysfunction.
(A) Evidence for involvement of adducin in nervous system function.
Adducin is found in the pre- and post-synapse of the NMJ in the fruit fly, and regulates synaptic plasticity. Pielage et al. (2011) and Wang et al. (2011)
Mice lacking β-adducin exhibit impaired synaptic plasticity and learning. Porro et al. (2010)
β-adducin is required for stable synapses and learning in “environmentally-enriched” environments. Bednarek and Caroni (2011)
Memory retention in C. elegans is regulated by adducin. Vukojevic et al. (2012)
(B) Evidence that neurological disease is associated with altered adducin.
Mutations in γ-adducin are associated with inherited cerebral palsy. Kruer et al. (2013)
Chorein, a protein responsible for a movement disorder in humans, interacts with β-adducin. Shiokawa et al. (2013)
(C) Evidence that misregulated adducin is associated with ALS and models of ALS.
Elevated levels of phospho-adducin in patients with ALS at autopsy. Hu et al. (2003)
Elevated levels of phospho-adducin in a murine model of ALS. Shan et al. (2005)
Knockdown of α-adducin in a murine model of ALS results in longer animal survival. Gallardo et al. (2014)
Knockdown of α-adducin in astrocytes from murine ALS co-cultured with motoneurons results in motoneuron survival. Gallardo et al. (2014)
The RNA-DNA binding protein, TDP-43, regulates β-adducin transcript stability. Costessi et al. (2014)
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FIGURE 3 | Adducin maintains presynaptic cytoskeletal organization, and also regulates contacts between the presynaptic terminal and muscle.
(A) Schematic model showing action of adducin (“Hts”) in stabilizing actin-spectrin interactions in the motoneuron axon and presynaptic region (green). The
actin-capping function of Hts may restrict actin-based outgrowths that participate in synapse elaboration. Postsynaptically (red), Hts can inhibit adhesion between
muscle and bouton. (B) Schematic of Drosophila wild-type larval body wall muscles (red) being contacted by a motoneuron (green). (C,D) Knockdown of presynaptic
adducin/Hts causes both overgrowth of the synaptic arbor and its retraction from the muscle. The same phenotype is seen in Hts mutant larvae. Overgrowth of the
synaptic arbor is also seen with postsynaptic overexpression of Hts, probably as a result of reducing adhesion between nerve and muscle. (E) Post-synaptic loss of
Hts prevents synaptic growth, possibly due to increased adhesion between nerve and muscle. The same phenotype is seen with presynaptic overexpression of Hts,
probably due to inhibition of actin-based outgrowths.
cells upon loss of cell-cell adhesions where it participates in
mitotic spindle assembly (Chen et al., 2011; Chan et al., 2014).
Interestingly, the nuclear localization and export signals are
conserved in Hts, and Hts can localize to the muscle nucleus
where it may regulate the export of transcripts that encode for
the PAR-1 and CaMKII kinases, but not for transcripts that
encode for Dlg (Wang et al., 2014; Figure 2). These various
results raise the interesting possibility that Hts/adducin may
shuttle between the NMJ and the nucleus in its regulation of the
synapse. There is considerable evidence that protein trafficking
occurs from the synapse to the nucleus especially with regard
to activity-dependent gene expression (Kaushik et al., 2014).
Furthermore, there is increasing recognition of misregulation of
localized translation at the synapse in ALS, and adducin may also
be involved in this process (Sephton and Yu, 2015).
CONCLUSIONS
There are many independent primary causes for developing
ALS. Mutations have been found in many genes in FALS
involved in disparate processes including mutations in SOD1,
TDP-43, C9ORF72 and other genes. Furthermore, the sporadic
(non-familial) form of ALS has been associated with other
risk factors and it is likely that ALS is a heterogeneous
disease in which a variety of distinct initiating factors
leads to common clinical manifestations. Current evidence
suggests that the motoneuron loss in murine models of ALS
are non-cell autonomous and require interactions between
motoneurons, corticospinal tract neurons and their non-
neuronal neighbors such as microglia, astrocytes and/or
terminal Schwann cells. A particularly malicious aspect to
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ALS, and one that leads to the rapid decline of affected
patients, is the inability of synaptic terminals to innervate
their targets, particularly muscle, and especially respiratory
muscle. This failure of synaptic connectivity might hinge on
the ability of adducin to act with interacting proteins to
permit strengthening of weakened synapses and allow the
NMJ to ‘‘hang on’’ simultaneously to both terminal axons and
muscle. The possible involvement of adducin and phospho-
adducin in ALS suggests strategies for treatment. For instance,
if the phosphorylation of adducin leads to some of the
neurodegenerative changes, one approach would be to attempt
to dephosphorylate adducin, or to inhibit the phosphorylation
of adducin which could lead to a strengthening of the pre-
and post-synaptic contacts, but which might exhibit less
plasticity. This effect might be achieved pharmacologically by
interfering with protein phosphorylation using compounds that
block protein phospho-sites with sugar residues (Shan et al.,
2012).
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